Pleksilasina

Pleksilasina, also known as pleksil, is a synthetic antibiotic belonging to the pleuromutilin class. It is primarily used in veterinary medicine to treat bacterial infections in animals, particularly in poultry and pigs. Pleksilasina works by inhibiting the synthesis of bacterial cell walls, leading to the death of the infected cells.

The drug was first developed in the Soviet Union in the 1960s and has since been used in various countries around the world. It is available in different forms, including injectable solutions and powders, which can be mixed with water or feed for oral administration.

Pleksilasina is effective against a wide range of Gram-positive and Gram-negative bacteria, making it a versatile antibiotic. However, like all antibiotics, its use should be carefully monitored to prevent the development of antibiotic resistance. In some regions, the use of pleksilasina has been restricted or banned due to concerns about its potential impact on the development of antibiotic resistance in bacterial populations.

In human medicine, pleksilasina is not commonly used due to the availability of more specific and effective antibiotics. Its use in humans is generally limited to specific cases where other treatments have failed or are not suitable. As with any antibiotic, the use of pleksilasina in humans should be prescribed by a healthcare professional and used under strict medical supervision.